Danaher Corporation $DHR Shares Bought by Mirova

Mirova raised its stake in shares of Danaher Corporation (NYSE:DHR) by 479.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,049 shares of the conglomerate’s stock after purchasing an additional 16,590 shares during the quarter. Mirova’s holdings in Danaher were worth $3,975,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Sivia Capital Partners LLC grew its stake in Danaher by 6.3% during the 2nd quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after purchasing an additional 119 shares during the last quarter. Foundations Investment Advisors LLC lifted its holdings in shares of Danaher by 5.2% during the second quarter. Foundations Investment Advisors LLC now owns 2,403 shares of the conglomerate’s stock worth $475,000 after purchasing an additional 119 shares during the period. Cetera Investment Advisers boosted its position in Danaher by 8.1% in the second quarter. Cetera Investment Advisers now owns 109,731 shares of the conglomerate’s stock valued at $21,676,000 after buying an additional 8,260 shares during the last quarter. Intech Investment Management LLC increased its holdings in Danaher by 15.8% in the 2nd quarter. Intech Investment Management LLC now owns 16,896 shares of the conglomerate’s stock worth $3,338,000 after buying an additional 2,305 shares during the period. Finally, Pinnacle Wealth Planning Services Inc. increased its holdings in Danaher by 13.9% in the 2nd quarter. Pinnacle Wealth Planning Services Inc. now owns 3,296 shares of the conglomerate’s stock worth $651,000 after buying an additional 402 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

NYSE:DHR opened at $191.43 on Thursday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. The company has a 50 day moving average price of $216.19 and a 200-day moving average price of $215.14. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $242.80. The firm has a market cap of $135.36 billion, a price-to-earnings ratio of 37.98, a price-to-earnings-growth ratio of 2.65 and a beta of 0.93.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.14 by $0.09. The firm had revenue of $6.84 billion for the quarter, compared to the consensus estimate of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.14 earnings per share. Equities research analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a dividend of $0.40 per share. This is a boost from Danaher’s previous quarterly dividend of $0.32. The ex-dividend date is Friday, March 27th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. Danaher’s payout ratio is 25.40%.

Insider Buying and Selling at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have commented on DHR shares. Jefferies Financial Group lifted their price objective on shares of Danaher from $255.00 to $265.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. TD Cowen reiterated a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. KeyCorp restated an “overweight” rating on shares of Danaher in a research report on Thursday, January 29th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a report on Monday, December 29th. Finally, Argus set a $265.00 price target on Danaher in a research report on Wednesday, January 14th. Nineteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $253.55.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.